Literature DB >> 1376540

Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate.

J Neyts1, R Snoeck, D Schols, J Balzarini, J D Esko, A Van Schepdael, E De Clercq.   

Abstract

Several sulfated polysaccharides (dextran sulfate, pentosan polysulfate, heparin) and copolymers of acrylic acid with vinylalcohol sulfate have proved to be potent inhibitors of human cytomegalovirus (CMV) infectivity in vitro. Sulfated alpha-cyclodextrins are only weak inhibitors of CMV. A close correlation was found between the 50% inhibitory concentrations of the sulfated polymers for CMV cytopathogenicity, virus-cell binding, and expression of immediate early antigens (IEA) in human embryonic lung (HEL) cells. CMV particles bound specifically to heparin-Sepharose. Sulfated polymers specifically eluted the virus particles from this matrix. Enzymatic digestion of cell surface heparan sulfate, but not of chondroitin sulfate, prevented the cells from being infected with CMV. Moreover, radiolabeled CMV bound efficiently to, and were infective for wild-type Chinese hamster ovary (CHO) cells, whereas virus binding to, and infection of, mutant CHO cell lines that were deficient in either all glycosaminoglycans or heparan sulfate only was significantly impaired. The mechanism of action of the sulfated polymers can be attributed to an inhibitory effect on the binding of CMV particles to the host cells. Presumably, the sulfated polymers interact with the viral envelope site(s) involved in the attachment of the CMV virions to cell surface heparan sulfate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376540     DOI: 10.1016/0042-6822(92)90680-n

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety.

Authors:  M L Heil; A Albee; J H Strauss; R J Kuhn
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 3.  Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.

Authors:  D Shukla; P G Spear
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 4.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

5.  Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.

Authors:  T Ueno; Y Eizuru; H Katano; T Kurata; T Sata; S Irie; K Ogawa-Goto
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

6.  Isolation of a laminin-binding protein from the protozoan parasite Leishmania donovani that may mediate cell adhesion.

Authors:  A Ghosh; K Bandyopadhyay; L Kole; P K Das
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

7.  Binding of Sindbis virus to cell surface heparan sulfate.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 8.  Protein-glycosaminoglycan interactions: infectiological aspects.

Authors:  D Sawitzky
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

9.  The Importance of Heparan Sulfate in Herpesvirus Infection.

Authors:  Christopher D O'Donnell; Deepak Shukla
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

10.  Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.

Authors:  B C Herold; S I Gerber; B J Belval; A M Siston; N Shulman
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.